Source: International Congress 2017 – What is the future for paediatric respiratory physiology and sleep?
Disease area: Paediatric lung diseases, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
I. Azevedo (Porto, Portugal). Paediatric sleep apnoea syndrome and cardiovascular risk factors in the generation XXI cohort. 1796

Member's Comments

No comment yet.

Related content which might interest you: Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Menopause and cardiovascular risk factors in sleep apnea Source: Eur Respir J 2006; 28: Suppl. 50, 200s Year: 2006 Predictors of sleep apnea syndrome high risk in an Italian general population sample Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 Association between childhood obstructive sleep apnoea and risk of early osteoporosis. Source: International Congress 2019 – Evaluation of breathing in children when they are asleep, healthy or ill Year: 2019 Prevalence of obstructive sleep apnea syndrome in patients with risk factors for cardiovascular diseases in a large population in Zaragoza (Spain) Source: International Congress 2014 – Sleep disordered breathing 3 Year: 2014 Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment Source: Eur Respir J 2002; 20: 1511-1518 Year: 2002 Prevalence and risk factors of obstructive sleep apnea syndrome in a population of upper Egypt Source: Annual Congress 2010 - Screening for sleep-disordered breathing Year: 2010 Obstructive sleep apnoea as a risk factor for incident metabolic syndrome: a joined Episono and HypnoLaus prospective cohorts study Source: Eur Respir J, 52 (5) 1801150; 10.1183/13993003.01150-2018 Year: 2018 Obstructive sleep apnea syndrome and cardiovascular diseases risk in patients with COPD Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012 Obstructive sleep apnea syndrome as factor of arrhythmic syndrome emergence and increase of cardiovascular risk in patients with COPD Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing Year: 2013 Obstructive sleep apnoea is not a risk factor for incident hospitalised depression: a historical cohort study Source: Eur Respir J, 49 (6) 1601361; 10.1183/13993003.01361-2016 Year: 2017 The evaluation of risk of obstructive sleep apnea syndrome in individuals with dysglycaemia Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012 Sleep apnoea and hypoventilation syndromes - cardiometabolic consequences Source: International Congress 2018 – PG7 Sleep-disordered breathing - diagnosis and therapy Year: 2018 Obstructive sleep apnoea and cardiovascular events in a Chinese cohort Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Gout increases the risk of coronary heart disease among patients with obstructive sleep apnea: A nationwide population-based cohort study Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity Year: 2015 Is obstructive sleep apnoea a risk factor for cardiovascular disease? Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy Year: 2005 Obstructive sleep apnea and cardiovascular risk in Chinese population: a Meta-analysis Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 Sleep apnoea as a risk factor for stroke Source: 5th Sleep and Breathing Conference Year: 2019 Prevalence of symptoms and risk of sleep apnea in the Iranian population Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Association of cardiovascular diseases, metabolic syndrome and obstructive sleep apnea: Data from 1,000 Japanease PSG cases Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012